Your browser doesn't support javascript.
loading
T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma.
Ogawa, Hiromi; Luxardi, Guillaume; Kirane, Amanda; Kulkarni, Rajan; Monjazeb, Arta M; Cheng, Michelle Y; Ma, Chelsea; Maverakis, Emanual.
Afiliação
  • Ogawa H; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA; Department of Dermatology, University of California, Los Angeles, School of Medicine, Los Angeles, California, USA.
  • Luxardi G; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA.
  • Kirane A; Department of Surgery, University of California, Davis, School of Medicine, Los Angeles, California, USA.
  • Kulkarni R; Department of Dermatology, University of California, Los Angeles, School of Medicine, Los Angeles, California, USA.
  • Monjazeb AM; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA.
  • Cheng MY; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA.
  • Ma C; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA.
  • Maverakis E; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA. Electronic address: emaverakis@ucdavis.edu.
J Invest Dermatol ; 138(6): 1442-1445, 2018 06.
Article em En | MEDLINE | ID: mdl-29291382
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article